Harrow Health(IMMY)

Imprimis Pharmaceuticals和 Compounding Pharmacy

淘沙见金2017-10-30 11:45

这个制药公司Imprimis Pharmaceuticals $Imprimis Pharmaceuticals, Inc.(IMMY)$ 大涨，原因是因为公司称将会提供比AGN的干眼症治疗药物Restasis更为便宜的替代选择。这个药物第一个月只需要不到1美元，以后每个月花费79美元。对比Restasis每年的花费高达5000美元一年确实便宜不少。听起来很美好...查看全文

Vodka配鱼油救命药2017-10-20 09:45

$Imprimis Pharmaceuticals, Inc.(IMMY)$
IMMY买入原因：今天IMMY发的干眼症药物为Restasis的仿制药，RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%，现有竞争对手仅有Shire’s idra，占20%的市场。IMMY的仿制药由于是走低价路线，有可...查看全文

TLS美股研究2017-04-09 21:31

回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88，也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注，眼科市场天花板逐渐打开，公司高管参与增发，市值迷你，会是小黑马吗 查看全文

$Imprimis制药(IMMY)$ 8-K - Current report Filed: 2018-12-31 AccNo: 0001493152-18-018103 Size: 87 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis制药(IMMY)$ 8-K - Current report Filed: 2018-12-17 AccNo: 0001493152-18-017569 Size: 7 MBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-12-17 AccNo: 0001493152-18-017569 Size: 7 MBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...

$Imprimis Pharmaceuticals, Inc.(IMMY)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-11-23 AccNo: 0001493152-18-016669 Size: 58 KB 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-11-23 AccNo: 0001493152-18-016669 Size: 58 KB 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-11-13 AccNo: 0001493152-18-015759 Size: 72 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-13 AccNo: 0001493152-18-015757 Size: 5 MB 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-11-13 AccNo: 0001493152-18-015689 Size: 36 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-11-06 AccNo: 0001493152-18-015232 Size: 25 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 内部交易: 2018-11-01,Director,Kammer Robert J ,卖出,10000普通股, $4.21